Phaseline

Targets › BIRC5

BIRC5 (Baculoviral IAP repeat-containing protein 5): drug programs, companies and trials

4 programs from 4 companies in 8 trials: 4 Phase 2, 4 Phase 1; Oncology; next expected readout Dec 2026.

Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis. Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis. (UniProt, O15392)

Open in Phaseline: the race on BIRC5, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Roswell Park Cancer InstituteSVN53-67/M57-KLH Peptide Vaccine
Survivin peptide vaccine
BIRC5Phase 2Glioblastoma; Partial Response of Multiple Myeloma or Plasma Cell LeukemiaDec 2026
ImmunoVaccine Technologies, Inc. (IMV Inc.)DPX-Survivac
Survivin-targeted immunogenic peptide vaccine
BIRC5Phase 2Ovarian Cancer; Relapsed Diffuse Large B-cell Lymphoma; Advanced Cancer; Breast Cancer–
Children's Oncology GroupSurVaxM
Survivin-based cancer vaccine
BIRC5Phase 1MedulloblastomaDec 2027
Mustafa Khasraw, MBChB, MD, FRCP, FRACPP30-EPS Vaccine
Peptide-based tumor-associated antigen vaccine targeting EphA2, CMV pp65, and Survivin lin
EPHA2, BIRC5Phase 1Glioma, MalignantFeb 2028

Conditions

Ovarian Cancer (1) Relapsed Diffuse Large B-cell Lymphoma (1) Advanced Cancer (1) Breast Cancer (1) Glioblastoma (1) Partial Response of Multiple Myeloma or Plasma Cell Leukemia (1) Medulloblastoma (1) Glioma, Malignant (1)

Modalities

mixed (3), protein or peptide (1)

Companies

ImmunoVaccine Technologies, Inc. (IMV Inc.) (1) Roswell Park Cancer Institute (1) Children's Oncology Group (1) Mustafa Khasraw, MBChB, MD, FRCP, FRACP (1)

Related targets

EPHA2 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.